Work for Onconova Therapeutics, Inc.?

Claim Your Profile

Onconova Therapeutics, Inc. Logo Image

Onconova Therapeutics, Inc.

Most Recent Annual Report

Upgrade your company profile to unlock all of your annual report content on AnnualReports.co.uk

2017 Annual Report and Form 10K

Onconova Therapeutics, Inc.

Onconova Therapeutics, Inc. has reached its limit for free report views.

Onconova Therapeutics, Inc. does not currently have any hardcopy reports on AnnualReports.co.uk. Click the button below to request a report when hardcopies become available.

Upgrade your company profile to unlock all of your annual report content on AnnualReports.co.uk

Archived Annual Reports

About Onconova Therapeutics, Inc.

11-50 Employees
Based in Newtown, Pennsylvania

Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with a primary focus on Myelodysplastic Syndromes (MDS). Rigosertib, Onconova's lead candidate, is a proprietary Phase 3 small molecule agent, which the Company believes blocks cellular signaling by targeting RAS effector pathways.

Ticker:
ONTX
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol